Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
94
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer

Tong Yu1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Jinglue Song1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Hui Zhou1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Tingyu Wu1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Zhonglin Liang1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Peng Du1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Chen-Ying Liu1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of China
,
Guanghui Wang3 Guizhou Provincial People’s Hospital, Guizhou, People’s Republic of ChinaCorrespondence[email protected]
,
Long Cui1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1838-4471
ORCID Icon &
Yun Liu1 Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Colorectal Cancer Research Center, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1581-1589 | Published online: 17 Feb 2021

References

  • Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–259. doi:10.1097/01.sla.0000217629.94941.cf16858188
  • Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428. doi:10.1172/JCI3910419487818
  • Kahlert C, Lahes S, Radhakrishnan P, et al. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clinical Cancer Res. 2011;17(24):7654–7663. doi:10.1158/1078-0432.CCR-10-281622042972
  • Wu W, Ren Z, Li P, et al. Six1: a critical transcription factor in tumorigenesis. Int J Cancer. 2015;136(6):1245–1253. doi:10.1002/ijc.2875524488862
  • Ono H, Imoto I, Kozaki K, et al. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene. 2012;31(47):4923–4934. doi:10.1038/onc.2011.64622286765
  • Kahlert C, Lerbs T, Pecqueux M, et al. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer. Int J Cancer. 2015;137(9):2104–2113. doi:10.1002/ijc.2959625951369
  • Liu Y, Wang G, Yang Y, et al. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner. Oncogene. 2016;35(21):2789–2800. doi:10.1038/onc.2015.34226387538
  • Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.24556840
  • Reichenberger KJ, Coletta RD, Schulte AP, Varella-Garcia M, Ford HL. Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res. 2005;65(7):2668–2675. doi:10.1158/0008-5472.CAN-04-428615805264
  • Zhao H, Xu Z, Qin H, Gao Z, Gao L. miR-30b regulates migration and invasion of human colorectal cancer via SIX1. Biochem J. 2014;460(1):117–125. doi:10.1042/BJ2013153524593661
  • Wang CA, Jedlicka P, Patrick AN, et al. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest. 2012;122(5):1895–1906. doi:10.1172/JCI5985822466647
  • Ng KT, Man K, Sun CK, et al. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer. 2006;95(8):1050–1055. doi:10.1038/sj.bjc.660339917008870
  • Zeng J, Shi R, Cai CX, et al. Increased expression of Six1 correlates with progression and prognosis of prostate cancer. Cancer Cell Int. 2015;15:63. doi:10.1186/s12935-015-0215-z26161040

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.